Diabetes and Hypertension
Part of NephTimes Diseases and Conditions
Advertisement
Meta-analyses reaffirmed cardiovascular and renal benefits of long-acting GLP-1RAs for patients with type 2 diabetes.
Researchers examined the effects of the GLP-1RA cotadutide on UACR, glycemic control, and body weight.
Research explored kidney outcomes among young patients receiving glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
Researchers assessed how prescription rates of SGLT2i were affected when DKD risk was predicted by a KidneyIntelX test.
A study examined the association of ankle-brachial index and CKD progression with type 2 diabetes and elevated BMI.
Babak Orandi spoke with us about a study showing that GLP-1 drugs have benefits for kidney transplant recipients with T2D.
Research examined kidney endpoints between patients with type 2 diabetes after initiating an SGLT2i or GLP-1RA.
In a Kidney Action Week session, Drs. Swapnil Hiremath and Jordana Cohen discussing management of resistant high BP with CKD.
SC0062 met the 12-week primary end point of a reduction in proteinuria in a study cohort with diabetic kidney disease (DKD).
A team analyzed sotagliflozin's effects on hemoglobin in patients with stage 3-4 CKD and type 2 diabetes.
Do GLP-1 receptor agonists reduce the risk of important clinical outcomes? Can patients without diabetes benefit from them?
The FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes.
A secondary analysis of DCP trial data sought to understand the effects of thiazide diuretics on kidney outcomes.
The renal effects and safety of acetazolamide in patients with type 1 diabetes was the subject of a recent study.
A study evaluated kidney outcomes of ARNI therapy versus ACEI/ARB for TMA related to malignant hypertension.
A study examined the efficacy of adding SZC to allow patients with stage 3-4 DKD to maintain treatment with RAASi.
Researchers studied risk of postoperative AKI with perioperative hypotension- versus hypertension-avoidance strategies.
A study examined an association between hyperglycemic crises at diabetes diagnosis and a higher risk of developing CKD.
A study examined the associations of systolic blood pressure with mortality and hospital readmission post-AKI.
The accuracy of continuous glucose monitoring versus self-monitored blood glucose in hemodialysis patients is not well known.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.